Logo for ME Therapeutics Holdings Inc.
METX

ME Therapeutics Holdings Inc.

Status
Active
Issued & Outstanding23,634,438
Reserved for Issuance10,503,890
Currency
CSE Index

About

ME Therapeutics Holdings Inc.

Listing date
October 12, 2023

ME Therapeutics is an early stage Vancouver based biotechnology company involved in the discovery and development of novel immuno oncology therapeutics targeting immune suppression in cancer. Our main focus is on overcoming the suppressive effects of an important class of immune cells called myeloid cells in order to enhance anti-tumour immunity.